Long-Acting Lenacapavir + Cabotegravir: Affordable HIV Treatment?
3 Articles
3 Articles
DOH Boosts HIV Education, Treatment In Northern Mindanao
The Department of Health (DOH) 10 (Northern Mindanao) is intensifying its education campaign on awareness and treatment of human immunodeficiency virus (HIV) among younger populations and communities in Northern Mindanao. In a press briefing on Thursday, Dr. Wellaflor Kindom Brito, head of DOH-10’s Infectious Diseases Cluster, said the cumulative total of HIV cases in the region has reached 4,008 as of March 2025. Brito, however, observed notabl…
Long-Acting Lenacapavir + Cabotegravir: Affordable HIV Treatment?
In a groundbreaking development poised to redefine HIV treatment paradigms in Africa, a recent study explores the transformative potential and cost-effectiveness of combining long-acting injectable antiretrovirals—lenacapavir and cabotegravir. This innovative therapeutic approach stands on the cusp of revolutionizing adherence, viral suppression, and ultimately, the trajectory of HIV epidemics across the continent. Published in Nature Communicat…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium